Can a medical need clause help manage the growing costs of prescription drugs in the EU?

Publisher： Cambridge University Press

E-ISSN： 1744-134x|11|2|179-192

ISSN： 1744-1331

Source： Health Economics, Policy and Law, Vol.11, Iss.2, 2015-09, pp. : 179-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Information and diffusion of new prescription drugs

By Serra-Sastre Victoria   McGuire Alistair  

Applied Economics, Vol. 45, Iss. 15, 2013-05 ,pp. : 2049-2057

Routledge Ltd

Access to resources Recommend Favorite

Measuring the Economic Costs and Benefits of the EU

By Minford Patrick  

Open Economies Review, Vol. 17, Iss. 4-5, 2006-12 ,pp. : 509-524

Springer Publishing Company

Access to resources Recommend Favorite

Does certificate of need affect cardiac outcomes and costs?

By Ho Vivian  

International Journal of Health Care Finance and Economics, Vol. 6, Iss. 4, 2006-12 ,pp. : 300-324

Springer Publishing Company

Access to resources Recommend Favorite

Demand for prescription drugs under non-linear pricing in Medicare Part D

By Jung Kyoungrae   Feldman Roger   McBean A.  

International Journal of Health Care Finance and Economics, Vol. 14, Iss. 1, 2014-03 ,pp. : 19-40

Springer Publishing Company

Access to resources Recommend Favorite

Can democracy help? Growth and ethnic divisions

By Bluedorn J.C.  

Economics Letters, Vol. 70, Iss. 1, 2001-01 ,pp. : 121-126

Elsevier

Access to resources Recommend Favorite